Lymphoplasmacytic Lymphoma Recruiting Phase 2 / 3 Trials for Doxorubicin (DB00997)

Indication	Status	Phase
DBCOND0031072 (Lymphoplasmacytic Lymphoma)	Recruiting	2 / 3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04799275	Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma	Treatment	Azacitidine (DB00928) Cortisone (DB14681) Cyclophosphamide (DB00531) Doxorubicin (DB00997) Methylprednisolone (DB00959) Prednisone (DB00635) Rituximab (DB00073) Sulfate ion (DB14546) Vincristine (DB00541)